U.S. Biotech company CohBar develops mitochondria-based therapeutics for age-related diseases
3 years ago
1.36K
U.S. biotech company CohBar is developing mitochondria-based therapeutics for age-related diseases. One America’s Stephanie Myers spoke with CohBar CEO Steven Engle about the progress and clinical programs they are developing to combat these diseases.
Loading 10 comments...
-
0:30
One America News Network
15 hours agoGeorge Clooney Begs Biden to Quit | TONIGHT on TIPPING POINT 🟧
41.9K26 -
1:44
KSHB
4 years agoLawrence-based biotech company develops possible COVID-19 therapy
31 -
0:50
Newsy
3 years agoBiotech Company Working On Coronavirus Antibody Detection Patch, Beads
756 -
2:06
KNXV
3 years agoArizona biotech company Sotira, working to create nasal spray as alternative to COVID-19 vaccine
35 -
2:28
EntertainmentVideos
3 years agoBad Company *
11 -
3:26
The Nomad Explorer
3 years agoPower Company Returns!
741 -
1:32
WXYZ
4 years agoMetro Detroit company develops disinfectant for essential workers
45 -
5:01
KenyonGrills
3 years agoKenyon Company Background
88 -
2:18
KMGH
3 years agoIn Good Company: Gatortailz
19 -
4:33
acrazycanuck
3 years agoBIOTECH PENNYSTOCKS
40